Exploring the Demand for Cell-Based Assay Software and Services in Pharmaceutical R&D
The global cell based assays market size is expected to reach US$ 14.7 billion in 2025. It is expected to reach US$ 25.5 billion by 2032, growing at a CAGR of 8.2% during the forecast period (2025 – 2032). The growth is driven by rising R&D investments, increasing prevalence of chronic diseases, and advancements in cell assay technologies, such as 3D cell culture assay optimization.